Androgen receptor remains critical for cell-cycle progression in androgen-independent CWR22 prostate cancer cells. Yuan X, Li T, Wang H, Zhang T, Barua M, Borgesi RA, Bubley GJ, Lu ML, Balk SP, Hematology/Oncology Division, Beth Israel Deaconess Medical Center, Boston, MA

Research output: Contribution to journalShort surveypeer-review

Fingerprint

Dive into the research topics of 'Androgen receptor remains critical for cell-cycle progression in androgen-independent CWR22 prostate cancer cells. Yuan X, Li T, Wang H, Zhang T, Barua M, Borgesi RA, Bubley GJ, Lu ML, Balk SP, Hematology/Oncology Division, Beth Israel Deaconess Medical Center, Boston, MA'. Together they form a unique fingerprint.

Medicine & Life Sciences